Paul Goldberg

Paul Goldberg

Editor & Publisher

Paul Goldberg is the editor and publisher of The Cancer Letter. He joined the publication in 1986.

His coverage has had a profound impact on the field of oncology, leading to numerous Congressional investigations, and helped change policy, regulation, and standards of care.

Paul’s reporting has been recognized by the Washington DC Professional Chapter of the Society of Professional Journalists, the Gerald Loeb Awards, the Association of Health Care Journalists, and the Newsletter and Electronic Publishers Foundation.

His articles have appeared in The New York Times, The Wall Street Journal, The Washington Post and The Washington Monthly, and he has been featured on 60 Minutes, 20/20, CNN and NPR. He is also a novelist and author of nonfiction books.

His author website is www.paulgoldberg.com

Paul graduated from Duke University with a B.A. in economics in 1981.
Books
Latest Stories
FDA’s Harpreet Singh: Overall survival data tells the full story of immune checkpoint inhibitor benefit in NSCLC Pooled analysis finds correlations between early endpoints and OS in ICI trials
Regulatory News
When conducting a randomized clinical trial of a treatment regimen based on an immune checkpoint inhibitor, trial sponsors should include overall survival as an endpoint, FDA officials say.
ODAC gives thumbs-up to imetelstat for MDS, upholding the value of transfusion independence
Regulatory News
The FDA Oncologic Drugs Advisory Committee voted 12:2 to recommend approval of the drug imetelstat for a myelodysplastic syndrome indication.
Radiation oncologist, global health expert C. Norman Coleman dies of sarcoma at 79
Obituary
In September, Norm Coleman received great news: he qualified for the Ironman 70.3 World Championship in New Zealand. 
Population scientist Monica Baskin is the “Jackie Robinson” of cancer center deputy directors
Free
As a new deputy director at UPMC Hillman Cancer Center, Monica Baskin has assumed a level of responsibility that is unusual, if not unprecedented, for a population scientist at an NCI-designated cancer center.
University of Maryland’s Owonikoko: What it means to be a Black director of an NCI-designated cancer center
Conversation with The Cancer Letter
A month after reporting to work in the top job at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Taofeek K. Owonikoko reflected on the obligations that come with being a Black director of an NCI-designated cancer center.

Login